Key Takeaways

  • Johnson & Johnson announced a global commitment to expand access to vision screening, cataract surgery, and essential ophthalmic care

  • Existing initiatives have reached nearly 60 million children through Sight For Kids and helped restore sight to more than 70,000 cataract patients

  • The company is supporting ophthalmic training, product donations, and affordable retinal imaging technology to improve eye care in underserved communities

Johnson & Johnson, with support from the Johnson & Johnson Foundation, announced a global commitment to expand access to eye care through partnerships, education, product donations, and advocacy aimed at reducing preventable vision loss.

The commitment was highlighted at the inaugural Global Summit for Eye Health, co-hosted by the Government of Antigua and Barbuda in technical collaboration with the World Health Organization (WHO), with support from the International Agency for the Prevention of Blindness (IAPB).

According to the company, more than 2 billion people worldwide experience poor vision, including more than 1 billion whose vision loss could have been prevented or treated. More than 90% of vision loss cases are preventable or treatable through interventions such as corrective eyeglasses and cataract surgery.

“Vision shapes how we learn, work and experience the world around us, yet too many people are living with vision impairment that could be prevented or treated with access to quality eye care,” said Jacqueline Henderson, company group chair, Vision, Johnson & Johnson.

The company's ongoing initiatives include Sight For Kids, a school-based eye health program established with Lions Clubs International Foundation in 2002. The program has reached nearly 60 million children through vision screenings, examinations, and access to eyeglasses.

Through partnerships with organizations including SEE International, Johnson & Johnson has also supported cataract surgery programs that have restored sight to more than 70,000 patients in underserved communities.

Additional efforts include donations of IOLs, ophthalmic equipment, and surgical training resources through organizations such as the Cure Blindness Project.

The J&J Foundation's Impact Ventures fund is also supporting Phelcom Technologies in developing affordable handheld retinal imaging systems to improve screening and diagnosis in resource-limited settings.

Johnson & Johnson said it will continue collaborating with IAPB to promote eye health as a global public health priority. These activities are part of the company's broader J&J CareCommunity social impact platform.